An Open-Label Study to Evaluate PF-07994525 in Participants With Advanced Cancers

Recruiting

Phase 1

PF-07994525An Open-Label Study to Evaluate PF-07994525 in Participants With Advanced Cancers

Sponsor:

Pfizer

Code:

NCT07426757

Conditions

Advanced Malignancies

Advanced Cancer

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

PF-07994525

Midazolam

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2026-06-06. This information was provided to ClinicalTrials.gov by Pfizer on 2026-06-01.